G.R. Lane Holdings Limited – Trademark Portfolio
Entity Type: 98
G.R. Lane Holdings Limited holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 5 are pending. Notable registered marks include J and OLBAS.
Sisson Road
Gloucester GL2 0GR
Showing of trademarks Trademarks
Trademark Classifications
G.R. Lane Holdings Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does G.R. Lane Holdings Limited have?
G.R. Lane Holdings Limited has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 pending.
What trademark classes does G.R. Lane Holdings Limited file in?
G.R. Lane Holdings Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are G.R. Lane Holdings Limited's most well-known trademarks?
G.R. Lane Holdings Limited's registered trademark portfolio includes well-known marks such as J and OLBAS. These are among 2 currently registered trademarks in the portfolio.
What is G.R. Lane Holdings Limited's trademark registration success rate?
G.R. Lane Holdings Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 5 applications are pending review.